Welcome to LookChem.com Sign In|Join Free

CAS

  • or

694529-38-9

Post Buying Request

694529-38-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

694529-38-9 Usage

Description

(R)-[1-(4-nitrophenyl)ethyl]carbamic acid t-butyl ester is a t-butyl ester derivative of carbamic acid, featuring a 4-nitrophenyl group attached to the carbon atom. As a chiral compound, it possesses a unique three-dimensional arrangement of atoms, which is crucial in various applications. This chemical is widely utilized in the synthesis of pharmaceuticals and agrochemicals, but it requires careful handling due to its potential irritant and toxic properties.

Uses

Used in Pharmaceutical Industry:
(R)-[1-(4-nitrophenyl)ethyl]carbamic acid t-butyl ester is used as a reagent for the synthesis of various pharmaceutical compounds. Its chiral nature plays a vital role in the development of enantiomerically pure drugs, which can have different biological activities and reduce potential side effects.
Used in Agrochemical Industry:
In the agrochemical industry, (R)-[1-(4-nitrophenyl)ethyl]carbamic acid t-butyl ester is employed as a reagent in the production of chiral pesticides and other agrochemicals. Its use contributes to the development of more effective and environmentally friendly products.
Used in Asymmetric Synthesis Research:
(R)-[1-(4-nitrophenyl)ethyl]carbamic acid t-butyl ester is used as a significant molecule in the study of asymmetric synthesis. This research area focuses on the development of methods to produce chiral compounds with a specific arrangement of atoms, which is essential for creating enantiomerically pure compounds with desired biological activities.
Used in Chiral Resolution Techniques:
This chemical compound is also utilized in the study and development of chiral resolution techniques. These techniques aim to separate enantiomers, which can have different effects on biological systems, allowing for the production of more effective and safer drugs and chemicals.

Check Digit Verification of cas no

The CAS Registry Mumber 694529-38-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,9,4,5,2 and 9 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 694529-38:
(8*6)+(7*9)+(6*4)+(5*5)+(4*2)+(3*9)+(2*3)+(1*8)=209
209 % 10 = 9
So 694529-38-9 is a valid CAS Registry Number.

694529-38-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name (R)-[1-(4-nitrophenyl)ethyl]carbamic acid t-butyl ester

1.2 Other means of identification

Product number -
Other names (R)-tert-butyl 1-(4-nitrophenyl)ethylcarbamate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:694529-38-9 SDS

694529-38-9Relevant articles and documents

SULFONYL AMIDE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH

-

Page/Page column 47, (2009/04/24)

The present invention relates to a compound of the formula I wherein R1 to R6, A, B, n and m are as defined herein. Such novel sulfonyl amide derivatives are useful in the treatment of abnormal cell growth, such as cancer, in mammals. This invention also relates to a method of using such compounds in the treatment of abnormal cell growth in mammals, especially humans, and to pharmaceutical compositions containing such compounds.

NOVEL COMPOUNDS, ISOMER THEREOF OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME

-

Page/Page column 59-60, (2010/11/23)

This present invention relates to novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor (Vanilloid Receptor 1; VR1; TRPV1 )antagonist; and a pharmaceutical composition containing the same. The present invention

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 694529-38-9